The complete guideline has been received by 57% of adults, according to the European Commission
“The EU has kept its word.” With this assertion, the president of the European Commission, Ursula von der Leyen, celebrated this Tuesday that 70% of the adult population of the European Union has already received at least the first dose of one of the anticovid vaccines authorized by the European Agency. of Medicine (EMA). “Today we have achieved that goal,” added the German in a short statement without questions that she read in French, English and German. At the end of April she herself readjusted the calendar that proposed the achievement of this milestone for September 21 (the end of summer) thus bringing it forward two months; to July.
In full expansion of the Delta variant, considered more transmissible and virulent, many experts already consider that group immunity will require vaccination quotas above 70%. Today 57% of Europeans would have received the full guideline. “The update process has been very successful, but we must keep up the effort”
“This variant is very dangerous so I ask everyone who has the opportunity to get vaccinated, for their own health and to protect others,” insisted the head of the Community Executive
After the first few months in which Europe lags far behind other parts of the globe in the distribution of vaccines and immunization, the updated figures “place Europe among the world leaders,” stressed Von der Leyen.
Coinciding with the announcement of the massive purchase of doses with BioNTech-Pfizer three months ago, making this laboratory a supply reference also in 2022 and 2023 (a contract was signed that guarantees the delivery of 1.8 billion doses for those two years) Von der Leyen also opted “to focus on technologies that are working” and, specifically, for “messenger RNA vaccines” that today only the aforementioned BioNTech-Pfizer and Moderna use.
Then he reconsidered that message by not closing the purchase options to serums based on other technologies; kept the door open to new reinforcements of anticovid vials by AstraZeneca (with which he opened a legal dispute) and Janssen (Johnson & Johnson). “The EU will continue to provide sufficient volumes of vaccines,” stressed Von der Leyen on Tuesday.